Akbartabar Toori Mehdi, Kiani Faezeh, Sayehmiri Fatemeh, Sayehmiri Kourosh, Mohsenzadeh Yousof, Ostovar Rahim, Angha Parvin, Mohsenzadeh Yazdan
Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran.
Iran J Med Sci. 2018 Sep;43(5):449-465.
Chronic and abnormal increase of different types of dyslipidemia leads to some important diseases, such as constriction and abstraction of vessels in various parts of the body, especially in the heart. High lipid profile, such as increased total cholesterol and LDL as well as decreased HDL are recognized as cardiovascular disease risk factors. The present study aimed to estimate the prevalence of different types of dyslipidemia in Iran by a meta-analysis method.
A literature search for studies published during 1998-2015 was carried out using both Persian and English databases (SID, Magiran, IranMedex, MedLib, PubMed, and Scopus). Keywords such as lipid, dyslipidemia, CVD, cardiovascular risk factors, hypercholesterolemia, high LDL-C, low HDL-C, and prevalence were used in the search. Random-effects model was used for the analysis using STATA (version 11.2).
In total, 163 articles were identified of which 49 articles fulfilled the inclusion criteria. The estimated prevalence (95% confidence interval) of eligible articles for high cholesterol ≥200 mg/dl and ≥240 mg/dl was 42% (95% CI: 38-45) and 17% (95% CI: 14-20), respectively. Moreover, the prevalence (95% confidence interval) for high LDL-C ≥130 mg/dl and ≥160 mg/dl was 40% (95% CI: 32-48) and 19% (95% CI: 16-23), respectively. The pooled prevalence estimate for low HDL-C (<40 among males, <50 among females) was 43% (95% CI: 33-53) in both sexes of the Iranian people. All types of lipid component abnormalities (hypercholesterolemia, high LDL-C, and low HDL-C) were more prevalent in women.
The results indicate that the prevalence of different types of dyslipidemia in Iran is substantial. Given the risk of complications (e.g. cardiovascular disease and control of different types of dyslipidemia) in Iranian people, it is important to reduce the burden of cardiovascular diseases.
不同类型血脂异常的慢性和异常增加会导致一些重要疾病,如身体各部位血管的收缩和狭窄,尤其是心脏部位。高脂质状况,如总胆固醇和低密度脂蛋白增加以及高密度脂蛋白降低,被认为是心血管疾病的危险因素。本研究旨在通过荟萃分析方法估计伊朗不同类型血脂异常的患病率。
使用波斯语和英语数据库(SID、Magiran、IranMedex、MedLib、PubMed和Scopus)对1998 - 2015年期间发表的研究进行文献检索。检索中使用了脂质、血脂异常、心血管疾病、心血管危险因素、高胆固醇血症、高低密度脂蛋白胆固醇、低高密度脂蛋白胆固醇和患病率等关键词。使用STATA(版本11.2)进行随机效应模型分析。
总共识别出163篇文章,其中49篇符合纳入标准。符合条件的文章中,胆固醇≥200mg/dl和≥240mg/dl的估计患病率(95%置信区间)分别为42%(95%CI:38 - 45)和17%(95%CI:14 - 20)。此外,低密度脂蛋白胆固醇≥130mg/dl和≥160mg/dl的患病率(95%置信区间)分别为40%(95%CI:32 - 48)和19%(95%CI:16 - 23)。伊朗人群中,高密度脂蛋白胆固醇低(男性<40,女性<50)的合并患病率估计为43%(95%CI:33 - 53)。所有类型的脂质成分异常(高胆固醇血症、高低密度脂蛋白胆固醇和低高密度脂蛋白胆固醇)在女性中更为普遍。
结果表明伊朗不同类型血脂异常的患病率很高。鉴于伊朗人群中并发症的风险(如心血管疾病和不同类型血脂异常的控制),减轻心血管疾病负担很重要。